Apotex Wins Appelate Reversal In Ofloxacin Case

Law360, New York (July 12, 2007, 12:00 AM EDT) -- The U.S. Court of Appeals for the Federal Circuit has reversed a lower court's decision that Canadian generic drug maker Apotex Corp. infringed a patent covering antibacterial ear medicine, ruling that Daiichi Sankyo Co. Ltd.'s patent was invalid due to obviousness, and clearing the way for Apotex to market generic ofloxacin ear drops.

The Federal Circuit handed down its ruling Wednesday, striking down Daiichi's previous win in the U.S. District Court for the District of New Jersey, in which the lower court had held that Apotex...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.